AI
ETNB

Atom Investors’s 89bio ETNB Stock Holding History

Atom Investors’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-205,947
Closed -$2.02M – 671
2025
Q2 		$2.02M Buy
205,947
+112,780
+121% +$934K 0.18% 160
2025
Q1 		$677K Buy
+93,167
New +$815K 0.08% 263
2024
Q1 		– Sell
-10,970
Closed -$123K – 603
2023
Q4 		$123K Buy
+10,970
New +$101K 0.02% 416
2023
Q3 		– Sell
-14,081
Closed -$267K – 457
2023
Q2 		$267K Sell
14,081
-3,729
-21% -$65.5K 0.1% 203
2023
Q1 		$271K Buy
+17,810
New +$232K 0.15% 164
2022
Q4 		– Sell
-87,164
Closed -$505K – 251
2022
Q3 		$505K Buy
+87,164
New +$383K 0.18% 150

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Atom Investors's ETNB Position: Q3 2025 in Review

Atom Investors sold out of 89bio (ETNB) in Q3 2025, closing a stake of 205,947 shares — an estimated $2.02M sold.

Atom Investors first reported a position in ETNB in Q3 2022 and held it in 6 quarters. The position peaked at $2.02M in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Atom Investors reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 205,947 89bio shares in Q3 2025, an estimated $2.02M.
  • Atom Investors first reported a position in 89bio in Q3 2022 and held it in 6 quarters.
  • Atom Investors's 89bio position peaked at $2.02M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.